GlassScriptPhysician profile
Rabel Misbah Rameez
NPI 1043669260
$734.72
in general payments reported to CMS, 2019-2025
8 companies · $69.72 in 2025
The $69.72 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $287 · 2024: $378 · 2025: $69.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $270.60 | 2023-2024 | Ffrct |
| Medtronic, INC. | $248.33 | 2023-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Omniasecure Mri Surescan |
| Novartis Pharmaceuticals Corporation | $67.01 | 2023 | |
| Amgen INC. | $45.13 | 2023 | Repatha |
| Pfizer INC. | $34.64 | 2023 | |
| Boston Scientific Corporation | $25.57 | 2024 | Watchman Flx |
| Lexicon Pharmaceuticals, INC. | $22.79 | 2023 | Inpefa |
| Abbott Laboratories | $20.65 | 2023 | Cardiomems |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabel Rameez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.